Aptose Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
Thank you and welcome back to the 2022 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotechnology equity research analysts here at RBC. And we're pleased today to be joined by Aptose Biosciences. And joining us from the company, Dr. Bill Rice, Chairman, President and Chief Executive Officer; and also joined by Dr. Bejar, the Chief Medical Officer of Aptose.
Gentlemen, thanks for joining us today. Great to see you in person. It's been a long time. And perhaps, Bill, I can just flip it to you to give a brief intro on Aptose, your two lead assets, the changes that have really elapsed and the path forward for the company.
All right, will do. Well, thanks for the invitation to your fireside chat. And in return, we will recommend you come to San Diego for a fire pit chat with margaritas. So we'll have to do that soon.
Okay. So a little bit of a background on Aptose. So this is a clinical-stage
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
